Target Name: MIR2110
NCBI ID: G100302224
Other Name(s): hsa-miR-2110 | hsa-mir-2110 | MicroRNA 2110 | microRNA 2110 | mir-2110

MIR2110: A Potential Drug Target and Biomarker

Molecular Targets and Biomarkers

Molecular targets are potential drug targets that can be targeted by small molecules or antibodies to modulate the activity of a specific protein and have been identified as potential drug targets in various diseases, including cancer, cardiovascular diseases, and neurological disorders. Biomarkers are biomolecules that are used as indicators of the presence or absence of a particular disease or condition and can be used to monitor the progression of a disease.

MIR2110 is a gene that encodes a protein known as MIR2110, which is a member of the superfamily of cytoskeletal proteins known as the myosin regulatory subfamily 21 (MRS) proteins. MRS proteins are involved in the regulation of muscle contraction and have been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

MIR2110 has been shown to be involved in the regulation of muscle contractions and has been identified as a potential drug target in various diseases. For example, MIR2110 has been shown to be involved in the regulation of myocardial contractions in the heart and has been linked to the development of myocardial infarction, a common type of cardiovascular disease.

In addition to its potential role in the regulation of muscle contractions, MIR2110 has also been shown to play a role in the regulation of cell signaling pathways. For example, MIR2110 has been shown to be involved in the regulation of the TGF-β pathway, a pathway that is involved in the regulation of cell growth, differentiation, and survival.

MIR2110 has also been shown to be involved in the regulation of inflammation and has been linked to the development of various inflammatory diseases, including cancer and autoimmune disorders. For example, MIR2110 has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as TNF-伪, and has been linked to the development of inflammatory diseases.

In conclusion, MIR2110 is a gene that has been shown to be involved in a variety of biological processes and has been identified as a potential drug target in various diseases. Further research is needed to fully understand the role of MIR2110 in the regulation of muscle contractions, cell signaling pathways, and inflammation, as well as its potential as a drug target.

Protein Name: MicroRNA 2110

More Common Targets

MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2